Image credit: Alyson Martin

Is the DEA Opening a Door to Cannabis Cultivation for Research? Or Is It Continuing to Drag Its Feet?

The agency says it will respond to pending applications, but first it will propose new regulations—without a timeline.

Research
Regulation

House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling 

The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.

New York

New York Cannabis Regulators Celebrate 100-Store Milestone, Forecast Market Changes Ahead

On Thursday, the state’s cannabis regulators talked about pitfalls to avoid as New York’s market matures.